Trial reportAnnals of African medicine2025
Clinical and Radiographic Evaluation of Biodentine and Mineral Trioxide Aggregate as Indirect Pulp Capping Agents in Primary Molars: A Randomized Controlled Trial with 18-month Follow-up.
Trial report in Annals of African medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Regenerative Potential of Biodentine in Complex Endodontic Conditions: A Systematic Review of Clinical and Radiological Evidence.Medicina (Kaunas, Lithuania) · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIndirect pulp treatment (IPT) is a vital pulp therapy procedure which helps to preserve the vitality of the pulp in teeth with deep carious lesions. This study aimed to evaluate the clinical and radiographic success of Biodentine versus mineral trioxide aggregate (MTA) as indirect pulp capping materials in primary molars with reversible pulpitis.
methodsA total of 68 children aged 4-9 years with bilateral carious primary molars, showing no signs of irreversible pulpitis, were selected. They were divided into two groups: Group I received Biodentine and Group II received MTA. IPT was performed, followed by the placement of stainless steel crowns. Patients were recalled at 3, 6, 12, and 18 months for clinical and radiographic assessments.
resultsOut of the initial 68 participants, 50 completed the 18-month follow-up, resulting in 100 treated primary molars analyzed. The IPT success rates were 96% (48 out of 50) for Biodentine and 94% (47 out of 50) for MTA. No statistically significant difference in success rates was observed between the two materials.
conclusionBiodentine and MTA demonstrated similar clinical and radiographic success rates after 18 months of follow-up, indicating that both materials are effective for indirect pulp capping in primary molars.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.